The firm’s Antitrust practice was recognized among the top antitrust practices in the nation by Chambers USA and The Legal 500 in the publications’ 2024 editions. The Legal 500 ranked the practice in Tier 1, and Chambers USA ranked the practice among the top firms nationally and in DC. Chambers USA reported that clients and peers say, “The firm delivers excellent service in relationship management, responsiveness, work product and expertise.” Chambers USA and The Legal 500 also ranked partners John Schmidtlein and Ben Greenblum among the top antitrust lawyers in the nation. The publications perform in-depth client-focused research and are read by industry-leading companies and organizations worldwide.
John Schmidtlein was recognized as Band 1 in “Antitrust: Litigation Specialists” for DC and Band 2 nationally in Antitrust: Cartel by Chambers USA. John was also recognized among the “Leading Lawyers” in antitrust by The Legal 500. According to Chambers USA, clients report he “is an absolutely top lawyer. He is extremely intelligent, thoughtful and strategic.” John has represented clients in complex civil and criminal matters for more than 30 years, including numerous trials. He is co-chair of Williams & Connolly’s Antitrust practice group and focuses his practice on civil and criminal antitrust litigation and government investigations.
Ben Greenblum was also recognized among Chambers USA’s 2024 “Antitrust: Litigation Specialists” for DC. According to Chambers USA, clients report he “is thoughtful, strategic, thorough and easy to work with. He is a strong writer and outstanding oral advocate. He also has an in-depth knowledge of the pharmaceutical industry.” Ben has extensive experience in antitrust and other complex civil litigation. He is recognized as a leading member of the bar defending so-called “pay for delay” or “reverse payment” patent settlements from antitrust attack, serving as trial counsel in the first two such cases ever to go to jury verdict. With years of experience litigating such cases, Ben advises on all manner of antitrust issues arising from the Hatch-Waxman Act and food and drug law.
Click here to see the firm’s Antitrust practice profile by Chambers USA; and click here to see the firm’s profile by The Legal 500.